2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October

2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October


There are two likely reasons for the poor performance. For starters, some of the index's largest holdings moved notably lower after reporting their third-quarter earnings results.



from Biotech News